AEON Biopharma (AEON) Shares Outstanding (2020 - 2026)

AEON Biopharma has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $9.9 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 1686.03% year-over-year to $9.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.9 million (up 1686.03% YoY) and the FY2025 annual result came in at $9.9 million, up 1686.03% from the prior year.
• Shares Outstanding (Entity) declined to $9.9 million in Q4 2025 per AEON's latest filing, from $11.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $11.6 million in Q3 2025 and troughed at $95841.0 in Q1 2021.
• A 5-year average of $2.2 million and a median of $449755.5 in 2021 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) plunged 75.0% in 2023, then jumped 2023.24% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $340301.0 in 2021, then advanced by 12.65% to $383364.0 in 2022, then soared by 34.64% to $516147.0 in 2023, then grew by 7.63% to $555511.0 in 2024, then soared by 1686.03% to $9.9 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $9.9 million, $11.6 million, and $11.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.